Essential Hypertension

Showing NaN - NaN of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Essential Hypertension Trial in Seoul (D064 and D702, QD, D064 and Placebo of D702, QD, Placebo of D064 and D702, QD)

Recruiting
  • Essential Hypertension
  • D064 and D702, QD
  • +2 more
  • Seoul, Seongdong-gu, Korea, Republic of
    Hanyang University Seoul Hospital
Nov 7, 2023

Hypertension, Blood Pressure, Systolic Hypertension Trial in Seoul (CART-I Plus)

Recruiting
  • Hypertension
  • +6 more
  • CART-I Plus
  • Seoul, Korea, Republic of
    Seoul National Univesity Hospital
Oct 11, 2023

Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,

Not yet recruiting
  • Essential Hypertension
  • Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
  • Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
  • Seoul, Gyeonggi-do, Korea, Republic of
  • +11 more
Sep 11, 2023

Essential Hypertension Trial in Seoul (L04RD1, L04TD3)

Completed
  • Essential Hypertension
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Aug 7, 2023

Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)

Not yet recruiting
  • Essential Hypertension
  • Primary Hypercholesterolemia
  • Seoul, Korea, Republic of
    Severance Hospital
Jun 26, 2023

Essential Hypertension Trial in Seoul (Irbesartan/Amlodipine, Irbesartan)

Recruiting
  • Essential Hypertension
  • Seoul, Korea, Republic of
    Hanyang University Seoul Hospital
Jul 24, 2022

Essential Hypertension Trial in Seoul (Irbesartan/Amlodipine low, Irbesartan/Amlodipine high, Irbesartan)

Recruiting
  • Essential Hypertension
  • Irbesartan/Amlodipine low
  • +2 more
  • Seoul, Korea, Republic of
    Severance Hospital
Jul 24, 2022

Essential Hypertension Trial in Seoul (Fimasartan/Amlodipine)

Completed
  • Essential Hypertension
  • Seoul, Korea, Republic of
    Boryung Pharmaceutical Co., Ltd
Jul 28, 2021

Amlodipine Verses S Amlodipine in Essential Hypertension

Unknown status
  • Essential Hypertension
  • S-amlodipine 2.5mg
  • Amlodipine 5mg
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Nov 10, 2020

Essential Hypertension, Dyslipidemia Trial in Seoul (Fimasartan/Amlodipine, Rosuvastatin, Fimasartan/Amlodipine, Fimasartan,

Completed
  • Essential Hypertension
  • Dyslipidemia
  • Fimasartan/Amlodipine, Rosuvastatin
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 7, 2019

Essential Hypertension Trial in Seoul

Completed
  • Essential Hypertension
    • Seoul, Korea, Republic of
      Yoon Jun Kim
    Feb 10, 2019

    Essential Hypertension Trial in Korea, Republic of (CS8635 20/5/12.5mg and , OlmetecĀ® Plus 20/12.5mg and )

    Completed
    • Essential Hypertension
    • CS8635 20/5/12.5mg and placebo
    • OlmetecĀ® Plus 20/12.5mg and placebo
    • Ansan, Korea, Republic of
    • +38 more
    Dec 20, 2018

    Essential Hypertension Trial in Korea, Republic of (S-amlodipine 2.5mg + Chlorthalidone 25mg, S-amlodipine 2.5mg + Telmisartan

    Unknown status
    • Essential Hypertension
    • S-amlodipine 2.5mg + Chlorthalidone 25mg
    • S-amlodipine 2.5mg + Telmisartan 40mg
    • Anyang, Dongan-gu, Korea, Republic of
    • +9 more
    Jul 20, 2017

    Essential Hypertension Trial in Worldwide (LCZ696, Olmesartan, Placebo of LCZ696)

    Completed
    • Essential Hypertension
    • Beijing, Beijing, China
    • +49 more
    Nov 8, 2016

    Essential Hypertension Trial in Seoul (Telmisartan/Amlodipine+Hydrochlorothiazide, Telmisartan/Amlodipine, Placebo for

    Completed
    • Essential Hypertension
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Nov 22, 2016

    Essential Hypertension Trial in Worldwide (LCZ696, Amlodipine, Placebo)

    Completed
    • Essential Hypertension
    • Shijiazhuang, Hebei, China
    • +27 more
    Oct 1, 2015

    Essential Hypertension Trial in Worldwide (Olmesartan, Placebo, LCZ696)

    Completed
    • Essential Hypertension
    • Chongqing, Chongqing, China
    • +77 more
    Oct 1, 2015

    Essential Hypertension Trial in Worldwide (LCZ696, Amlodipine, Hydrochlorothiazide (HCTZ))

    Completed
    • Essential Hypertension
    • Chongqing, Chongqing, China
    • +32 more
    Sep 22, 2015

    Diseases of the Circulatory System, Essential Hypertension Trial in Seoul (Telmisartan, Atorvastatin)

    Completed
    • Diseases of the Circulatory System
    • Essential Hypertension
    • Seoul, Korea, Republic of
      Chonbuk National University Hospital
    Oct 15, 2015

    Essential Hypertension, Hyperlipidemia Trial in Seoul (Atorvastatin, Losartan, Placebo)

    Completed
    • Essential Hypertension
    • Hyperlipidemia
    • Seoul, Korea, Republic of
      Korea University Guro Hospital
    Sep 21, 2015

    Essential Hypertension Trial in Korea, Republic of (Amlodipine 5mg, Amlodipine 5mg, Candesartan cilexetil 16mg, Amlodipine 10mg,

    Unknown status
    • Essential Hypertension
    • Amlodipine 5mg
    • +2 more
    • Anyang-si, Korea, Republic of
    • +18 more
    Feb 16, 2015

    Essential Hypertension Trial in Korea, Republic of (Candesartan cilexetil 16mg, Amlodipine 10mg, Candesartan cilexetil 16mg)

    Unknown status
    • Essential Hypertension
    • Candesartan cilexetil 16mg
    • Amlodipine 10mg, Candesartan cilexetil 16mg
    • Anyang-si, Korea, Republic of
    • +18 more
    Feb 16, 2015

    Essential Hypertension Trial in Seoul (Fimasartan, Valsartan)

    Completed
    • Essential Hypertension
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 5, 2014

    Essential Hypertension Trial in Korea, Republic of (Amlodipine 5mg, Amlodipine 10mg, Candesartan Cilexetil 8mg)

    Unknown status
    • Essential Hypertension
    • Amlodipine 5mg
    • +3 more
    • Bundang, Korea, Republic of
    • +19 more
    Apr 29, 2014

    Essential Hypertension, Hyperlipidemia Trial in Seoul (Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg, atorvastatin

    Completed
    • Essential Hypertension
    • Hyperlipidemia
    • Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg
    • atorvastatin 40mg
    • Seoul, Korea, Republic of
      Severance Hospital
    Jul 31, 2013